Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.140
-0.125 (-9.88%)
Jan 21, 2026, 5:22 PM CET

STO:NEWBRY Cash Flow Statement

Millions SEK. Fiscal year is Sep - Aug.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '25 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Net Income
-23.88-23.88-15.41-19.43-14.67-6.06
Depreciation & Amortization
1.011.010.820.340.09-
Asset Writedown & Restructuring Costs
4.664.660.910.910.910.66
Stock-Based Compensation
-0.11-0.11-0.090.070.15-
Other Operating Activities
-1.91-0.09-0.130.25-0.13-
Change in Accounts Receivable
8.458.45-7.07-11.161.26-2.1
Change in Inventory
-4-4-2.89-0.33-1.77-
Change in Other Net Operating Assets
-7.921.60.146.12-0.853.07
Operating Cash Flow
-23.71-12.37-23.71-23.23-15-4.44
Sale (Purchase) of Intangibles
-2.21-2.21-2.91-0.86-24.4-25.18
Investment in Securities
---0.05---3.98
Investing Cash Flow
-1.64-2.21-2.95-0.86-24.4-29.17
Long-Term Debt Issued
--17.31-21.78-
Long-Term Debt Repaid
--1.54-2.03-0.72-7.13-
Net Debt Issued (Repaid)
-1.54-1.5415.27-0.7214.64-
Issuance of Common Stock
15.3815.3818.16-44.9547.94
Financing Cash Flow
13.8413.8433.44-0.7259.5947.94
Net Cash Flow
-11.51-0.746.78-24.8120.1914.34
Levered Free Cash Flow
-27.76-17.05-4.46-21.63-31.69-
Unlevered Free Cash Flow
-26.72-16.02-3.5-21.63-31.69-
Change in Working Capital
-3.476.05-9.82-5.37-1.360.96
Source: S&P Global Market Intelligence. Standard template. Financial Sources.